Skip to main content
Premium Trial:

Request an Annual Quote

Bavaria Grants Kinaxo $900K for Chemical Proteomics

NEW YORK (GenomeWeb News) – Kinaxo Biotechnologies has received a grant of €575,000 ($906,000) from the Bavarian Ministry of Economic Affairs, Infrastructure, Transport, and Technology.
 
Kinaxo plans to use the money to expand the uses for its chemical proteomics technology for identifying protein targets of compounds found in cell-based drug screens.
 
Martinsried, Germany-based Kinaxo’s Cellular Target Profiling technology was originally developed by the Max Planck Institute of Biochemistry, from which Kinaxo is a spin-off.
 
"This funding will allow us to significantly expand the scope and utility of our chemical proteomics capability, helping to demonstrate further valuable applications for broad adoption in the field of small molecule drug development," Kinaxo CEO Andreas Jenne said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.